In this exclusive AlumniTALK, Dr. George D. Yancopoulos CC’80, GSAS’86, PS’87, co-founder, president and chief scientific officer of Regeneron Pharmaceuticals, will discuss biotechnologies and therapy explorations aimed at addressing COVID-19, the most pressing public health infectious risk of our time.

Please send questions for the Q&A part of the discussion to ccalumni@columbia.edu.

Webinar link provided upon registration.